Showing results (2891-2900 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|August 1, 2020
Integrative Review of Managed Entry Agreements: Chances and LimitationsCarolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, et al.
Pharmacoeconomics|March 17, 2015
Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE programFrancisco Jódar-Sánchez, Amaia Malet-Larrea, José J Martín, et al.
Pharmacoeconomics|April 16, 2021
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised MedicineHeleen Vellekoop, Simone Huygens, Matthijs Versteegh, et al.
Pharmacoeconomics|September 19, 2002
Costs and effectiveness of using coumarins before, during and after coronary angioplastyJurrien M ten Berg, Johannas C Kelder, Thys H W Plokker, et al.
Pharmacoeconomics|September 19, 2002
Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniquesMark J C Nuijten, Frans Rutten
Pharmacoeconomics|September 20, 2002
Why has the use of health economic evaluation in Japan lagged behind that in other developed countries?Naoki Ikegami, Michael Drummond, Shunichi Fukuhara, et al.
Pharmacoeconomics|August 7, 2002
Cost of illness of Crohn's diseaseKeith Bodger
Pharmacoeconomics|January 8, 2003
Cost effectiveness and cost utility of acetylcysteine versus dimethyl sulfoxide for reflex sympathetic dystrophyHiske E M van Dieten, Roberto S G M Perez, Maurits W van Tulder, et al.
Pharmacoeconomics|December 18, 2002
Economic evaluations of varicella vaccination programmes: a review of the literatureNancy Thiry, Philippe Beutels, Pierre Van Damme, et al.
Pharmacoeconomics|December 18, 2002
Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studiesNiklas Zethraeus, Magnus Johannesson, Bengt Jönsson, et al.
Pageof 336